Skip to Main Content

Author Details

Ken Kikuchi
Kyoto Prefectural University of Medicine
2002
61
19
PMIDPaper TitleJournal TitlePublished Year
36866753<i>In ovo</i> chorioallantoic membrane assay as a xenograft model for pediatric rhabdomyosarcoma.Oncol Rep2023
36866753<i>In ovo</i> chorioallantoic membrane assay as a xenograft model for pediatric rhabdomyosarcoma.Oncol Rep2023
35949602Association of high cellular expression and plasma concentration of angiopoietin-like 4 with tongue cancer lung metastasis and poor prognosis.Oncol Lett2022
35949602Association of high cellular expression and plasma concentration of angiopoietin-like 4 with tongue cancer lung metastasis and poor prognosis.Oncol Lett2022
35727889The histone deacetylase inhibitor OBP-801 has in vitro/in vivo anti-neuroblastoma activity.Pediatr Int2022
35727889The histone deacetylase inhibitor OBP-801 has in vitro/in vivo anti-neuroblastoma activity.Pediatr Int2022
34187933Negative correlation of single-cell <i>PAX3:FOXO1</i> expression with tumorigenicity in rhabdomyosarcoma.Life Sci Alliance2021
33609318Proposal of a novel H category-based classification of colorectal liver metastases based on a Japanese nationwide survey.J Hepatobiliary Pancreat Sci2021
34187933Negative correlation of single-cell <i>PAX3:FOXO1</i> expression with tumorigenicity in rhabdomyosarcoma.Life Sci Alliance2021
33816783Development of non-viral, ligand-dependent, EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma.Mol Ther Oncolytics2021
34552155Reduced B7-H3 expression by PAX3-FOXO1 knockdown inhibits cellular motility and promotes myogenic differentiation in alveolar rhabdomyosarcoma.Sci Rep2021
34472721Inhibition of lipid metabolism exerts antitumor effects on rhabdomyosarcoma.Cancer Med2021
33816783Development of non-viral, ligand-dependent, EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma.Mol Ther Oncolytics2021
33609318Proposal of a novel H category-based classification of colorectal liver metastases based on a Japanese nationwide survey.J Hepatobiliary Pancreat Sci2021
34472721Inhibition of lipid metabolism exerts antitumor effects on rhabdomyosarcoma.Cancer Med2021
34552155Reduced B7-H3 expression by PAX3-FOXO1 knockdown inhibits cellular motility and promotes myogenic differentiation in alveolar rhabdomyosarcoma.Sci Rep2021
32294127Efficacy of adjuvant chemotherapy with S-1 in stage II oral squamous cell carcinoma patients: A comparative study using the propensity score matching method.PLoS One2020
32294127Efficacy of adjuvant chemotherapy with S-1 in stage II oral squamous cell carcinoma patients: A comparative study using the propensity score matching method.PLoS One2020
32489328Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cells.Cancer Cell Int2020
32847975The Novel Histone Deacetylase Inhibitor, OBP-801, Induces Apoptosis in Rhabdoid Tumors by Releasing the Silencing of <i>NOXA</i>.Mol Cancer Ther2020
33163518Does laparoscopic liver resection for colorectal liver metastases provide a true survival benefit compared with open liver resection?Hepatobiliary Surg Nutr2020
33163518Does laparoscopic liver resection for colorectal liver metastases provide a true survival benefit compared with open liver resection?Hepatobiliary Surg Nutr2020
32847975The Novel Histone Deacetylase Inhibitor, OBP-801, Induces Apoptosis in Rhabdoid Tumors by Releasing the Silencing of <i>NOXA</i>.Mol Cancer Ther2020
32489328Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cells.Cancer Cell Int2020
30365145OBPâ¿¿801, a novel histone deacetylase inhibitor, induces Mâ¿¿phase arrest and apoptosis in rhabdomyosarcoma cells.Oncol Rep2019
30655847Enhancement of cancer invasion and growth via the C5a-C5a receptor system: Implications for cancer promotion by autoimmune diseases and association with cervical cancer invasion.Oncol Lett2019
30365145OBPâ¿¿801, a novel histone deacetylase inhibitor, induces Mâ¿¿phase arrest and apoptosis in rhabdomyosarcoma cells.Oncol Rep2019
30904164Mutations in the RAS pathway as potential precision medicine targets in treatment of rhabdomyosarcoma.Biochem Biophys Res Commun2019
30720122[Erratum] OBPâ¿¿801, a novel histone deacetylase inhibitor, induces Mâ¿¿phase arrest and apoptosis in rhabdomyosarcoma cells.Oncol Rep2019
31053863A prospective evaluation of liquid biopsy for detecting MYCN amplification in neuroblastoma patients.Jpn J Clin Oncol2019
31053863A prospective evaluation of liquid biopsy for detecting MYCN amplification in neuroblastoma patients.Jpn J Clin Oncol2019
30904164Mutations in the RAS pathway as potential precision medicine targets in treatment of rhabdomyosarcoma.Biochem Biophys Res Commun2019
30720122[Erratum] OBPâ¿¿801, a novel histone deacetylase inhibitor, induces Mâ¿¿phase arrest and apoptosis in rhabdomyosarcoma cells.Oncol Rep2019
30655847Enhancement of cancer invasion and growth via the C5a-C5a receptor system: Implications for cancer promotion by autoimmune diseases and association with cervical cancer invasion.Oncol Lett2019
29277819Hepatic Resection Followed by Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma with Intrahepatic Dissemination.Anticancer Res2018
29277819Hepatic Resection Followed by Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma with Intrahepatic Dissemination.Anticancer Res2018
27840956MET/ERK2 pathway regulates the motility of human alveolar rhabdomyosarcoma cells.Oncol Rep2017
28981396Cancer-Specific Energy Metabolism in Rhabdomyosarcoma Cells Is Regulated by MicroRNA.Nucleic Acid Ther2017
27840956MET/ERK2 pathway regulates the motility of human alveolar rhabdomyosarcoma cells.Oncol Rep2017
28181419Anterior approach for right hepatectomy with hanging maneuver for hepatocellular carcinoma: a multi-institutional propensity score-matching study.J Hepatobiliary Pancreat Sci2017
28181419Anterior approach for right hepatectomy with hanging maneuver for hepatocellular carcinoma: a multi-institutional propensity score-matching study.J Hepatobiliary Pancreat Sci2017
28981396Cancer-Specific Energy Metabolism in Rhabdomyosarcoma Cells Is Regulated by MicroRNA.Nucleic Acid Ther2017
27107976Portal Vein Embolization Followed by Right-Side Hemihepatectomy for Hepatocellular Carcinoma Patients: A Japanese Multi-Institutional Study.J Am Coll Surg2016
27107976Portal Vein Embolization Followed by Right-Side Hemihepatectomy for Hepatocellular Carcinoma Patients: A Japanese Multi-Institutional Study.J Am Coll Surg2016
27255663IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma.Sci Rep2016
26494574Influence of the C5a-C5a receptor system on breast cancer progression and patient prognosis.Breast Cancer2016
27895761C5a receptor expression is associated with poor prognosis in urothelial cell carcinoma patients treated with radical cystectomy or nephroureterectomy.Oncol Lett2016
26494574Influence of the C5a-C5a receptor system on breast cancer progression and patient prognosis.Breast Cancer2016
27895761C5a receptor expression is associated with poor prognosis in urothelial cell carcinoma patients treated with radical cystectomy or nephroureterectomy.Oncol Lett2016
27255663IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma.Sci Rep2016
  • 1 - 50 of 122

Recommended Authors

Children's Cancer Therapy Development Institute
Career Start Year 2016
Number of shared co-authors 9
National Cancer Institute, National Institutes of Health
Career Start Year 2008
Number of shared co-authors 3
University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 1
Institute of Pathology, Medical University of Innsbruck
Career Start Year 2007
Number of shared co-authors 0
University of California-Los Angeles
Career Start Year 2006
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 3
Johns Hopkins University School of Medicine
Career Start Year 2005
Number of shared co-authors 2
National Cancer Institute, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 3
University of California los angeles
Career Start Year 2001
Number of shared co-authors 1
Samsung Medical Center, Sungkyunkwan University
Career Start Year 2001
Number of shared co-authors 0
Institut Curie Hospital
Career Start Year 2001
Number of shared co-authors 1
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 3
Tianjin Medical University Cancer Institute and Hospital
Career Start Year 2000
Number of shared co-authors 0
Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)/CIBERONC
Career Start Year 2000
Number of shared co-authors 3
Washington University School of Medicine and Siteman Cancer Center
Career Start Year 1999
Number of shared co-authors 0
Nagasaki University Graduate School of Biomedical Sciences
Career Start Year 1997
Number of shared co-authors 2
Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu
Career Start Year 1996
Number of shared co-authors 3
Mount Sinai Hospital
Career Start Year 1994
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 1993
Number of shared co-authors 15
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 2
Servicio de Anatomia Patologica. Hospital Universitario Virgen del Rocio.
Career Start Year 1992
Number of shared co-authors 4
British Columbia Cancer Research Centre
Career Start Year 1989
Number of shared co-authors 5
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 0
IRCCS Istituto Ortopedico Rizzoli
Career Start Year 1987
Number of shared co-authors 4
Center for Cancer Research, National Cancer Institute
Career Start Year 1987
Number of shared co-authors 2
Georgetown University Medical Center, Georgetown University
Career Start Year 1986
Number of shared co-authors 5
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Career Start Year 1983
Number of shared co-authors 0
Osteosarcoma Institute
Career Start Year 1977
Number of shared co-authors 10
Center for Epigenetics, Van Andel Research Institute
Career Start Year 1971
Number of shared co-authors 4

Collaborators

Children's Cancer Therapy Development Institute
Co-authored papers 10
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Co-authored papers 6
University of Texas Health Science Center
Co-authored papers 4
Oregon Health & Science University
Co-authored papers 3
Oregon Health & Science University
Co-authored papers 3
University of Colorado Anschutz Medical Campus
Co-authored papers 2
Children's Cancer Therapy Development Institute
Co-authored papers 2
University of Miyazaki
Co-authored papers 2
University of Texas Health Science Center
Co-authored papers 2
Joslin Diabetes Center
Co-authored papers 2
Oregon Health & Science University
Co-authored papers 2
University Medical Center Freiburg, University of Freiburg
Co-authored papers 2
Institute for Frontier Medical Sciences, Kyoto University
Co-authored papers 1
Lillehei Heart Institute, University of Minnesota
Co-authored papers 1
Co-authored papers 1
The University of Texas Health Science Center at San Antonio
Co-authored papers 1
University of Utah
Co-authored papers 1
Department of Oncology and Children's Research Center, University Children's Hospital
Co-authored papers 1
Kyoto University
Co-authored papers 1
Germans Trias i Pujol Research Institute
Co-authored papers 1
Oregon Health & Science University
Co-authored papers 1
Co-authored papers 1
Kaohsiung Medical University
Co-authored papers 1
Co-authored papers 1
University of Texas Health Science Center at San Antonio
Co-authored papers 1
Oregon Health and Science University, 3710 SW US Veterans Hospital Rd
Co-authored papers 1
Co-authored papers 1
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1